Updated time: 2022-09-16 09:00:25
13A-1050817
TW I650419 、AU 2017326234、JP 6846524、KR 102291187、US 11,266,697 B2、CA 3,036,690、KR 10-2434566
We have generated a unique healthy mouse model before, which carries a lysine à arginine mutation at amino acid position 74 of the transcription factor EKLF. These mice, termed EKLF-GEM or EKLF (K74R), have extended life span and health span, and they are tumor resistant (PCT application submitted by Academia Sinica on Sept. 1, 2015). Using this model, we show that the tumor resistance of the EKLF (K74R) mice could be transferred to the wild type mice by bone marrow transplantation.
With further development, this unique hematopoictic/blood system could be used for treating cancers and for conferring healthy longevity/rejuvenescence to mammals including human.
The invention demonstrates for the first time the feasibility of transfer of the capability of tumor resistance, and likely the healthy longevity, between living organisms through a unique hematopoietic blood system carrying a specific amino acid substitution in a transcription factor.
No similar invention exists before.
Che-Kun James Shen、Yu-Chiau Shyu
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Transfer of the capability of tumor resistance through an unique hematopoietic/blood system